In order to validate this assumption, the cytokines for neutrophil recruitment, including CXCL1 and CXCL2 (De Filippo et al., 2013; Paudel et al., 2019), were examined in the cisplatin-treated tumor cells. Here, CXCL1 is linked to neoplasm.